GE HealthCare discloses FCPA reviews into China activities

GE

GE HealthCare said it is cooperating with reviews by the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) into potential violations of the Foreign Corrupt Practices Act (FCPA) in China.

GE disclosed the matter in a regulatory filing Tuesday. It said it voluntarily self-reported to the agencies beginning in 2018 regarding “tender irregularities and other potential violations of the FCPA relating to our activities in certain provinces in China.”

“We are fully cooperating with the reviews by these agencies and have implemented, and continue to implement, enhancements to our compliance policies and practices,” the company continued. “At this time, we are unable to predict the duration, scope, result, or related costs associated with these disclosures to the SEC and the DOJ. We also are unable to predict what, if any, action may be taken by the SEC or the DOJ or what penalties or remedial actions they may seek.”

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.